Results 131 to 140 of about 212,304 (319)

Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals

, 2018
Amanda Cole, Adrian Towse, Paula Lorgelly, Ryan Sullivan   +3 more
openalex   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

A study on influencers of total sales revenue of generic pharmaceutical companies in Indonesia [PDF]

This paper empirically examines the influence of firms’ one-year lagged of total new products (t-1), one-year lagged profitability (t-1), and market share of new products to firms’ amount of sales revenue in pharmaceutical generic companies in Indonesia.
Simanjuntak, Destrina Grace, Tjandrawinata, Raymond R.   +1 more
core   +1 more source

Sustainability in Analytical Chemistry Illustrated by Pharmaceutical Nitrosamine Testing

ELECTROPHORESIS, EarlyView.
ABSTRACT Following the valsartan scandal in 2018, the testing of drug substances and drug products for N‐nitrosamines has become a critical and mandatory quality control measure. The European Pharmacopoeia chapter 2.5.42 currently describes three analytical methods for this purpose: HPLC–MS/MS, GC–MS, and GC–MS/MS.
Felix Bredendiek, Sebastian Schmidtsdorff, Maria Kristina Parr   +2 more
wiley   +1 more source

International Cooperation in Pharmaceutical Research [PDF]

This paper aims at examining whether an increased stringency of Intellectual Property Right (IPR) protection is apt to stimulate international cooperation on research projects between developed and emerging countries.
Anna Rita Bennato, Laura Magazzini
core  

Continuities in Policies and Turnover Among Actors: Instrument Constituencies in French Primary Care Reforms

European Policy Analysis, EarlyView.
ABSTRACT Over the past decade, the concept of “instrument constituency” has been proposed as a way in which to bridge studies on policy networks and policy instruments. This concept focuses on policy networks composed of diverse actors who are brought together by the shared goal of promoting a specific instrument.
Noémie Morize
wiley   +1 more source

Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model

Cost Effectiveness and Resource Allocation
Objectives The population of older adults continues to grow in Iran, with pharmaceutical costs as a leading driver of household health-related costs.
Mehran Faraji, Tahereh Sharifi, Saeed Mohammad-pour, Javad Javan-Noughabi, Ali Aboutorabi, Shaghayegh yousefi, Mihajlo Jakovljevic   +6 more
doaj   +1 more source

The Economics of the Public Option: Evidence from Local Pharmaceutical Markets

, 2021
Juan Pablo Atal, José Ignacio Cuesta, Felipe González, Cristóbal Otero   +3 more
openalex   +1 more source

A call for ethical, equitable, and effective artificial intelligence to improve care for all people with epilepsy: A roadmap. A report by the ILAE Global Advocacy Council and Big Data Commission

Epilepsia, EarlyView.
Abstract The artificial intelligence (AI) revolution is upon us. It will inevitably form a central component of epilepsy workflows and patient advocacy. Therefore, it behooves us as health care providers to ride the crest of this wave and guide its direction for the benefit of all people with epilepsy.
Colin B. Josephson, Sandor Beniczky, Spiros Denaxas, Akio Ikeda, Lara Jehi, Angelina Kakooza Mwesige, Nathalie Jette, Gabriel Davis Jones, Philippe Ryvlin, Arjune Sen, Chahnez Charfi Triki, Gabriella Waters, Alla Guekht, J. Helen Cross   +13 more
wiley   +1 more source

The determinants of pricing in pharmaceuticals : are U.S. prices really higher than those of Canada? [PDF]

, 2007
This paper studies price determination in pharmaceutical markets using data for 25 countries, six years and a comprehensive list of products from the MIDAS IMS database.
Cabrales, Antonio, Jiménez-Martín, Sergi   +1 more
core   +1 more source